Sustaining PMI pricing

Decisions regarding corporate private healthcare provision are all too often made for the short-term win, the unbelievably low renewal price which proves too attractive to ignore, the quick hit of introducing an excess which drops expected costs by a magical 10%, moving to a new insurer renewal after renewal in search of better claims cost management. However, quick fixes are just that and by choosing such a strategy companies continue to sit upon an out-dated, expensive, unsophisticated dodo. So what to do? In a climate where budgets are being squeezed and the pressure on purchasers is ...